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	NEWS	
When I discuss the activities of the American College of
Cardiology (ACC), among the first I am likely to mention are
our Practice Guicelines .
Background . More than a decade ago the ACC, in col-
laboration with the American Heart Association (Ah1A),
began producing a series of educational documents describ-
ing the appropriate use of medical technologies in clinical
practice. The two organizations are justly proud of these
pioneering efforts that have attempted to bring scientific
analysis and expert consensus to a branch of clinical medi-
cine that has experienced an unprecedented proliferation of
useful, often lifesaving, technology .
It was in 1980 that Drs . Robert Brandenburg and Thomas
James, then Presidents of the ACC and ASIA, respectively,
conceived the idea of a joint task force to develop guidelines
in areas of controversy, often involving competing diagnos-
tic and therapeutic technologies .
Dr. Charles Fisch was appointed chairman of the parent
committee, named the Task Force on Assessment of Diag-
nostic and Therapeutic Cardiovascular Procedures, which
selects topics and appoints members expert in each topic to
serve on ad hoc writing subcommittees. The written charge,
which has reatained virtually unchanged until the present,
was as follows:
* The Task Force shall define the role of specific noninva-
sive and invasive procedures in the diagnosis and manage-
ment of cardiovascular disease .
® The Task Force shall address, when appropriate, the
contribution, uniqueness, sensitivity, specificity, indica-
tions, contraindications and cost-effectiveness of such
specific procedures .
These documents are written by physicians for physicians
and are intended to be educational . It was learned that
appointing only recognized experts led to a cacophony of
voices ("too many thoroughbreds"), and the process was
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strengthened by having a balance of general cardiologists
and those expert in the technology on the writing commit-
tees. A useful taxonomy was developed :
Indications for diagnostic procedures rind therapeutic
intc'rvenlions . Class I®General agreement that a procedure
or therapy is appropriate . Class 11---Diver, opinion as to
whether a procedure or therapy is appropriate : A) weight of
evidence in favor of appropriateness ; 13) weight of evidence
against appropriateness . Class 111--General agreement that
a procedure or therapy is nor appropriate .
Other changes occurred, pd_ .1aps the most evolutionary
of which was to write guidelines for the management of
clinical entities, such as myocardial infarction and heart
failure . Although cost-effectiveness was mentioned in the
charge, analysis of cost has yet to be undertaken in any of
the guidelines .
Published guidelines. The following ACC/AHA guide-
lines have thus far been published in JACC and Circulation :
Implantation of Cardiac Pacemaker and Antiarrhythmia De-
vices (August 1984; revised July 1991), Leonard S . Dreifus,
MD, Chairman
Exercise Testing (September 1986), Robert C . Schlant, MD,
Chairman
Clinical Use of Cardiac Radionuclide Imaging (December
1986), Robert A . O'Rourke, MD, Chairman
Coronary Angiography (October 1987), John Ross, Jr., MD,
Chairman
Percutaneous Transluminal Coronary Angioplasty (August
1988 ; revised December 1993), Thomas J
. Ryan, MD, Chair-
man
Ambulatory Electrocardiography (January 1989), Suzanne
B. Knoebel, MD, Chairman
Clinical Intracardiac Electrophysiologic Studies (December
1989), Douglas P . Zipes, MD, Chairman
Early Management of Patients With Acute Myocardial In-
farction (August 1990), Rolf M. Gunnar, MD, Chairman
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Clinical Application of Echocardiography (December 1990) .
Gordon A. Ewy, MD, Chairman
Coronary Artery Bypass Graft Surgery (March 1991), John
W. Kirklin, MD, Chairman
Cardiac Catheterization and Cardiac Catheterization Labo-
ratories (November 1991), Carl J. Pepine, MD, Chairman
Electrocardiography (March 1992), Robert C . Schlant, MD,
Chairman
Pare passu with the College's evolving experience in the
development of guidelines, powerful forces were gathering
that created new and possibly unrealistic expectations for
Practice Guidelines. Escalating health care costs, variation
in medical practice patterns, evidence that some health
services are of little value, public curiosity about the process
of clinical decision making and claims that various financial,
educational and organizational incentives can reduce inap-
propriate utilization are among the factors that have engen-
dered new expectations for Practice Guidelines .
Health system reform. Practice Guidelines have become
the great hope for health system reform. The Omnibus
Budget Reconciliation Act of 1989 (Public Law 101-239)
established the Agency for Health Care Policy and Research
(AHCPR) "to enhance the quality, appropriateness, and
effectiveness of health care services and access to such
services" (I [p . 11) . The AHCPR's appropriation for fiscal
year 1990 was nearly $100 million, of which $2 million was
obligated for Practice Guidelines . The AHCPR Practice
Guidelines are targeted to the primary care physician and the
"consumer," employ a clinical algorithm approach 1cf ACC/
AHA classification I to 111), are quite explicit about the
weight of the scientific evidence underlying each recommen-
dation and have broad representation on its "contractor
panels" in terms of gender, minority populations and geo-
graphic areas of the United States (I [p . 21). The AHCPR
recently published Practice Guidelines for the diagnosis and
management of unstable angina. The cost to the American
tax payer for this project was $927,000 (2) .
Yet we have never looked very carefully at the compli-
ance with guidelines, much less measured their effects in
terms of clinical and economic outcomes . "A valid practice
guideline is one that, if followed, will lead to the health and
cost outcomes projected for it" (3) . Validity in this sense is
yet to be established . I should like to see public monies spent
on studies of compliance with existing guidelines and their
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impact on outcomes, before subsidizing guidelines that may
duplicate the work of others .
If Practice Guidelines prove valid and are widely ac-
cepted, they could alleviate the ignorance and mistrust about
appropriate utilization, offer a legal standard in malpractice
litigation, become the basis for reimbursement, provide a
foundation for instruments to evaluate practitioner and
health system performance and avoid draconian alternative
measures to control medical costs .
It is clear that unexamined reliance on professional
judgment is no longer accepted. We are no longer trusted to
define medical practice ourselves . New standards of credi-
bility and accountability are demanded .
The future. What does this portend for the future of the
ACCI'AUA Task Force? Does the College have the re-
sources to develop guidelines according to the new expec-
tations? Should we concede that only government can
attract the broad participation in guideline development
necessary to achieve credibility'! Should we resign ourselves
to endorsing the guidelines developed by others to avoid
competing guidelines?
My answer to these questions is that our experience
during the "Fisch" era has firmly established our leadership
in Practice Guideline development, and we should enthusi-
astically continue our own efforts . Guideline development
remains fundamentally an educational exercise by physi-
cians for physicians . Broadening participation to include
"consumers" and other groups may increase political accep-
tance but is unlikely to change recommendations substan-
tively. Exhaustive literature review may provide a patina of
scientific validity but would be unlikely to uncover facts
unknown to those chosen for the writing committees .
Others may spend enormous sums for guideline develop-
ment and may achieve wide acceptance and dissemination of
their products . The College, mindful of the increasing scru-
tiny given to guidelines, should continue to play a construc-
tive, leadership role in guideline development . This is one of
our best educational activities .
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